Drug
Omega-3 capsules
Omega-3 capsules is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
1
25%
Ph early_phase_1
1
25%
Ph phase_2
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A1 (25.0%)
Trials by Status
completed125%
unknown375%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_2
High Dose Omega 3 in People at Risk for Dementia
NCT03926351
completednot_applicable
Omega-3 Dietary Supplements in Schizophrenia
NCT01786239
unknownphase_3
Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements
NCT02525107
unknownearly_phase_1
The Correlation Between Blood omega3 and ADHD
NCT02391428
Clinical Trials (4)
Showing 4 of 4 trials
NCT03926351Phase 2
High Dose Omega 3 in People at Risk for Dementia
NCT01786239Not Applicable
Omega-3 Dietary Supplements in Schizophrenia
NCT02525107Phase 3
Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements
NCT02391428Early Phase 1
The Correlation Between Blood omega3 and ADHD
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4